Phosphorylation of NMDA 2B at S1303 in human glioma peritumoral tissue: Implications for glioma epileptogenesis

Xiang Gao, Haiyan Wang, Shanbao Cai, M. Reza Saadatzadeh, Helmut Hanenberg, Karen E. Pollok, Aaron A. Cohen-Gadol, Jinhui Chen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Object. Peritumoral seizures are an early symptom of a glioma. To gain a better understanding of the molecular mechanism underlying tumor-induced epileptogenesis, the authors studied modulation of the N-methyl-d-aspartate (NMDA) receptor in peritumoral tissue. Methods. To study the possible etiology of peritumoral seizures, NMDA receptor expression, posttranslational modification, and function were analyzed in an orthotopic mouse model of human gliomas and primary patient glioma tissue in which the peritumoral border (tumor-brain interface) was preserved in a tissue block during surgery. Results. The authors found that the NMDA receptor containing the 2B subunit (NR2B), a predominantly extrasynaptic receptor, is highly phosphorylated at S1013 in the neurons located in the periglioma area of the mouse brain. NR2B is also highly phosphorylated at S1013 in the neurons located in the peritumoral area from human brain tissue containing a glioma. The phosphorylation of the extrasynaptic NMDA receptor increases its permeability for Ca2+ influx and subsequently mediates neuronal overexcitation and seizure activity. Conclusions. These data suggest that overexcitation of the extrasynaptic NMDA receptors in the peritumoral neurons may contribute to the development of peritumoral seizures and that the phosphorylated NR2B may be a therapeutic target for blocking primary brain tumor-induced peritumoral seizures.

Original languageEnglish (US)
Article numberE17
JournalNeurosurgical focus
Volume37
Issue number6
DOIs
StatePublished - Jan 1 2014

Fingerprint

Aspartic Acid
Glioma
Seizures
Phosphorylation
Neurons
Brain Neoplasms
Brain
Post Translational Protein Processing
Permeability
aspartic acid receptor
Neoplasms
Therapeutics

Keywords

  • Glioblastoma multiforme
  • NMDA
  • NR2B
  • Peritumoral seizures

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Phosphorylation of NMDA 2B at S1303 in human glioma peritumoral tissue : Implications for glioma epileptogenesis. / Gao, Xiang; Wang, Haiyan; Cai, Shanbao; Reza Saadatzadeh, M.; Hanenberg, Helmut; Pollok, Karen E.; Cohen-Gadol, Aaron A.; Chen, Jinhui.

In: Neurosurgical focus, Vol. 37, No. 6, E17, 01.01.2014.

Research output: Contribution to journalArticle

@article{9b4ef92d7e9048e5b098c67aaea60ef4,
title = "Phosphorylation of NMDA 2B at S1303 in human glioma peritumoral tissue: Implications for glioma epileptogenesis",
abstract = "Object. Peritumoral seizures are an early symptom of a glioma. To gain a better understanding of the molecular mechanism underlying tumor-induced epileptogenesis, the authors studied modulation of the N-methyl-d-aspartate (NMDA) receptor in peritumoral tissue. Methods. To study the possible etiology of peritumoral seizures, NMDA receptor expression, posttranslational modification, and function were analyzed in an orthotopic mouse model of human gliomas and primary patient glioma tissue in which the peritumoral border (tumor-brain interface) was preserved in a tissue block during surgery. Results. The authors found that the NMDA receptor containing the 2B subunit (NR2B), a predominantly extrasynaptic receptor, is highly phosphorylated at S1013 in the neurons located in the periglioma area of the mouse brain. NR2B is also highly phosphorylated at S1013 in the neurons located in the peritumoral area from human brain tissue containing a glioma. The phosphorylation of the extrasynaptic NMDA receptor increases its permeability for Ca2+ influx and subsequently mediates neuronal overexcitation and seizure activity. Conclusions. These data suggest that overexcitation of the extrasynaptic NMDA receptors in the peritumoral neurons may contribute to the development of peritumoral seizures and that the phosphorylated NR2B may be a therapeutic target for blocking primary brain tumor-induced peritumoral seizures.",
keywords = "Glioblastoma multiforme, NMDA, NR2B, Peritumoral seizures",
author = "Xiang Gao and Haiyan Wang and Shanbao Cai and {Reza Saadatzadeh}, M. and Helmut Hanenberg and Pollok, {Karen E.} and Cohen-Gadol, {Aaron A.} and Jinhui Chen",
year = "2014",
month = "1",
day = "1",
doi = "10.3171/2014.9.FOCUS14485",
language = "English (US)",
volume = "37",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "6",

}

TY - JOUR

T1 - Phosphorylation of NMDA 2B at S1303 in human glioma peritumoral tissue

T2 - Implications for glioma epileptogenesis

AU - Gao, Xiang

AU - Wang, Haiyan

AU - Cai, Shanbao

AU - Reza Saadatzadeh, M.

AU - Hanenberg, Helmut

AU - Pollok, Karen E.

AU - Cohen-Gadol, Aaron A.

AU - Chen, Jinhui

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Object. Peritumoral seizures are an early symptom of a glioma. To gain a better understanding of the molecular mechanism underlying tumor-induced epileptogenesis, the authors studied modulation of the N-methyl-d-aspartate (NMDA) receptor in peritumoral tissue. Methods. To study the possible etiology of peritumoral seizures, NMDA receptor expression, posttranslational modification, and function were analyzed in an orthotopic mouse model of human gliomas and primary patient glioma tissue in which the peritumoral border (tumor-brain interface) was preserved in a tissue block during surgery. Results. The authors found that the NMDA receptor containing the 2B subunit (NR2B), a predominantly extrasynaptic receptor, is highly phosphorylated at S1013 in the neurons located in the periglioma area of the mouse brain. NR2B is also highly phosphorylated at S1013 in the neurons located in the peritumoral area from human brain tissue containing a glioma. The phosphorylation of the extrasynaptic NMDA receptor increases its permeability for Ca2+ influx and subsequently mediates neuronal overexcitation and seizure activity. Conclusions. These data suggest that overexcitation of the extrasynaptic NMDA receptors in the peritumoral neurons may contribute to the development of peritumoral seizures and that the phosphorylated NR2B may be a therapeutic target for blocking primary brain tumor-induced peritumoral seizures.

AB - Object. Peritumoral seizures are an early symptom of a glioma. To gain a better understanding of the molecular mechanism underlying tumor-induced epileptogenesis, the authors studied modulation of the N-methyl-d-aspartate (NMDA) receptor in peritumoral tissue. Methods. To study the possible etiology of peritumoral seizures, NMDA receptor expression, posttranslational modification, and function were analyzed in an orthotopic mouse model of human gliomas and primary patient glioma tissue in which the peritumoral border (tumor-brain interface) was preserved in a tissue block during surgery. Results. The authors found that the NMDA receptor containing the 2B subunit (NR2B), a predominantly extrasynaptic receptor, is highly phosphorylated at S1013 in the neurons located in the periglioma area of the mouse brain. NR2B is also highly phosphorylated at S1013 in the neurons located in the peritumoral area from human brain tissue containing a glioma. The phosphorylation of the extrasynaptic NMDA receptor increases its permeability for Ca2+ influx and subsequently mediates neuronal overexcitation and seizure activity. Conclusions. These data suggest that overexcitation of the extrasynaptic NMDA receptors in the peritumoral neurons may contribute to the development of peritumoral seizures and that the phosphorylated NR2B may be a therapeutic target for blocking primary brain tumor-induced peritumoral seizures.

KW - Glioblastoma multiforme

KW - NMDA

KW - NR2B

KW - Peritumoral seizures

UR - http://www.scopus.com/inward/record.url?scp=84916888393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916888393&partnerID=8YFLogxK

U2 - 10.3171/2014.9.FOCUS14485

DO - 10.3171/2014.9.FOCUS14485

M3 - Article

C2 - 25434386

AN - SCOPUS:84916888393

VL - 37

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 6

M1 - E17

ER -